Correlation Between Eli Lilly and Gilead Sciences

Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Gilead Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Gilead Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eli Lilly and and Gilead Sciences, you can compare the effects of market volatilities on Eli Lilly and Gilead Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Gilead Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Gilead Sciences.

Diversification Opportunities for Eli Lilly and Gilead Sciences

0.67

Correlation Coefficient

Eli Lilly  Gilead Sciences

Poor diversification

The 3 months correlation between Eli and Gilead is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Gilead Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gilead Sciences and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Gilead Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gilead Sciences has no effect on the direction of Eli Lilly i.e., Eli Lilly and Gilead Sciences go up and down completely randomly.

Pair Corralation between Eli Lilly and Gilead Sciences

Assuming the 90 days trading horizon Eli Lilly is expected to generate 2.2 times less return on investment than Gilead Sciences. In addition to that, Eli Lilly is 1.24 times more volatile than Gilead Sciences. It trades about 0.04 of its total potential returns per unit of risk. Gilead Sciences is currently generating about 0.12 per unit of volatility. If you would invest  185,732  in Gilead Sciences on December 29, 2024 and sell it today you would earn a total of  24,268  from holding Gilead Sciences or generate 13.07% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Eli Lilly and  vs.  Gilead Sciences

Eli Lilly

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Eli Lilly is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Gilead Sciences

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Gilead Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Gilead Sciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eli Lilly and Gilead Sciences

The main advantage of trading using opposite Eli Lilly and Gilead Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Gilead Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gilead Sciences will offset losses from the drop in Gilead Sciences' long position.

The idea behind Eli Lilly and and Gilead Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.